LSD use in American adults rose over 50 percent between 2015 and 2018, a surge that one researcher attributes to rising national chaos.
A network of psychedelic healthcare providers offers a comprehensive global directory of psychedelic clinical trials that are actively enrolling.
A group of Canadian researchers proposes clear guidelines for academic researchers to keep the field of psychedelic science transparent.
Researchers at the University of North Carolina use new techniques to create medicines that duplicate the effectiveness of ketamine and psilocybin as treatments for depression without the psychoactive effects.
The company is researching the anti-inflammatory properties of psychedelics to create new drugs with reduced psychoactivity.
Critical research sponsored by the Eleusis Benefit Corporation could lead to new drugs for Alzeimers and Retinal Disease.
The company is developing a technology that seeks to personalize psychedelic therapy experiences for patients.
In this video interview, Orsini describes how he used LSD to help treat his own autism, and what he’s doing to increase awareness for psychedelic-assisted approaches to treating autism.
The benefits of MDMA-assisted psychotherapy appear to grow over time, but the study lacks racial diversity.
The psychiatrist and psychedelics expert Julie Holland discusses why human connection is important for both physical wellbeing and for the body politic in her new book, Good Chemistry.